Chinaamc Hang Seng Hong Kong Biotech Index ETF(03069.HK) Rises 3.08% Intraday with NAV Per Unit at HK$14.046

NewTimeSpace News: As of 13:13 on July 6, 2026, Chinaamc Hang Seng Hong Kong Biotech Index ETF(03069.HK) increased by 3.08% and traded at HK$14.410. The ETF recorded a trading volume of 10,798,600 units with a turnover of HK$157 million and an average traded price of HK$14.501. Its current net asset value per unit is HK$14.046, total assets under management stand at HK$2.253 billion, and each trading lot comprises 100 units.

Chinaamc Hang Seng Hong Kong Biotech Index ETF(03069.HK) tracks the Hang Seng Hong Kong Listed Biotech Index. Its constituent stocks consist of the 30 largest-capitalization biotech companies listed in Hong Kong that are eligible for Stock Connect trading, focusing on innovative drugs, biotechnology, medical devices, healthcare services and other related sectors.

NewTimeSpace Disclaimer: All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.